Back to Journals » Clinical Ophthalmology » Volume 15

Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials

Total article views   HTML views PDF downloads Totals
9,780 Dovepress* 6,777+ 211 6,988
PubMed Central* 3,003 298 3,301
Totals 9,780 509 10,289
*Since 8 October 2021

View citations on PubMed and Google Scholar